Monitoring heart risk with a wearable sensor in diabetes
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a wearable chest sensor (called HEMOTAG) to monitor heart events in people with long-standing Type 2 diabetes who also have heart disease or specific diabetes-related complications. The sensor is worn at home for short periods to catch early signs of heart trouble, aiming to improve personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have had Type 2 diabetes for at least 5 years (whether or not you take insulin).
- You have heart or blood vessel disease (like coronary artery disease, stroke, or peripheral artery disease) — OR — you have one of these diabetes complications: eye disease (retinopathy), kidney disease (low eGFR or protein in urine), nerve damage, or high inflammation (hs-CRP) along with at least two of: high blood pressure (for 6+ months), high LDL cholesterol, obesity, or smoking history.
- You agree to wear a HEMOTAG chest sensor at home at least 3 days a week for 30 days at the start, at 6 months, and after any heart-related hospital stays.
- You are willing to have standard clinic visits and blood tests (NT-proBNP).
- You can provide signed consent and speak English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for blood markers that may help explain or predict heart problems in people who have type 2 diabetes and heart failure. To join, you may also need to be having a planned heart procedure where doctors can collect study information.
This trial tests a heart-focused prevention approach to lower the risk of cardiac (heart) events in adults with type 2 diabetes. It may help by targeting early stress on the heart measured with a specific blood test.
This study tests whether using a smartphone app and a wearable device (like a fitness tracker), along with artificial intelligence (AI), can help people with type 2 diabetes better manage their condition and prevent complications. You would need to provide lifestyle information and use the devices for 3 months.
This trial checks whether a medical patch called HEMOTAG can help doctors predict or track how patients do shortly after a hospital stay for worsening heart failure. It may help improve early monitoring and treatment decisions after discharge.
This study uses a wearable wrist device to monitor your health data and look for early signs of heart problems. It's for people with or without heart disease, and involves wearing a watch-like device and using a smartphone app.
This trial uses a Holter monitor to track heart rate changes and autonomic nerve function in people with diabetes, to see if it can predict diabetic autonomic neuropathy. It may help identify early problems and guide therapy.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.